IBRANCE is the first CDK4/6 inhibitor to show benefit in a large Phase 3 trial in first-line HR+, HER2+ metastatic breast cancer, in combination with anti-HER2 and endocrine therapy
First and only PARP inhibitor to improve overall survival in early breast cancer
This acquisition positions Suven as a key player in one of the fastest growing segments of the Pharma CDMO landscape
Emcure has launched an awareness campaign to help spread the word about male anemia
Roger Dansey to become Interim Chief Oncology Officer and Johanna Bendell to join Pfizer as Oncology Chief Development Officer
He did Master’s of Pharmacy (Pharmaceutical Technology, Formulations) from National Institute of Pharmaceutical Education and Research, Mohali and Bachelor of Pharmacy from Osmania University
Max Healthcare Institute has reported total income of Rs. 1,748.30 crores during the period ended September 30, 2024
The group plans to establish new hospitals in Kerala developing large health cities in Kochi and Kozhikode
These initiatives signify a substantial boost to healthcare infrastructure across India, aligned with the Prime Minister’s mission of ensuring quality healthcare services nationwide
Subscribe To Our Newsletter & Stay Updated
